Jim Cramer Says Markets Shouldn't Have Been Surprised by Pfizer Approval

The Street 2021-08-23

Views 1

Jim Cramer said markets shouldn’t have been surprised by the FDA approval of Pfizer and BioNtech’s COVID vaccine. Here’s how he’s approaching markets Monday.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
U.K. Approval of Pfizer Vaccine Gives Jim Cramer More Confidence in U.S. Rollout
play
01:14

U.K. Approval of Pfizer Vaccine Gives Jim Cramer More Confidence in U.S. Rollout
Jim Cramer Says Monday's Pfizer-Driven Market Rally Is Justified
play
01:23

Jim Cramer Says Monday's Pfizer-Driven Market Rally Is Justified
Jim Cramer: Pfizer Doesn't Deserve to Be a Pariah
play
03:38

Jim Cramer: Pfizer Doesn't Deserve to Be a Pariah
Jim Cramer: Pfizer Should Buy Biohaven
play
02:40

Jim Cramer: Pfizer Should Buy Biohaven
Why Jim Cramer Would Buy Pfizer Here
play
00:54

Why Jim Cramer Would Buy Pfizer Here
Why Jim Cramer Is Leaning Towards a Pfizer Vaccine Candidate Right Now
play
00:43

Why Jim Cramer Is Leaning Towards a Pfizer Vaccine Candidate Right Now
Jim Cramer Says Sell Pfizer Stock Monday
play
01:21

Jim Cramer Says Sell Pfizer Stock Monday
Why Jim Cramer Is Watching the Transports After the Pfizer Vaccine Approval
play
01:55

Why Jim Cramer Is Watching the Transports After the Pfizer Vaccine Approval
Jim Cramer Explains Why Market Is Up Despite  Pfizer Production Problems
play
01:38

Jim Cramer Explains Why Market Is Up Despite  Pfizer Production Problems
Pfizer vaccine announcement has 'massive impact' on markets
play
02:49

Pfizer vaccine announcement has 'massive impact' on markets
Pfizer Vaccine News Gives Markets 'Light at End of Tunnel:' Analyst
play
01:11

Pfizer Vaccine News Gives Markets 'Light at End of Tunnel:' Analyst
Jim Cramer's Market Advice Ahead of Expected Pfizer Vaccine Rollout
play
01:35

Jim Cramer's Market Advice Ahead of Expected Pfizer Vaccine Rollout